Production (Stage)
Lexeo Therapeutics, Inc.
LXEO
$4.00
$0.123.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.85% | -22.61% | -10.26% | -10.29% | 60.59% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.25% | 88.80% | 12.45% | -28.43% | 7.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.53% | -20.91% | -9.99% | -10.57% | 59.37% |
|
|
|||||
| Total Current Assets | -16.53% | -20.91% | -9.99% | -10.57% | 59.37% |
| Net Property, Plant & Equipment | -4.02% | -5.36% | -3.89% | -2.17% | -3.24% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.12% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -14.46% | -15.49% | -9.45% | -9.94% | 52.50% |
|
|
|||||
| Total Accounts Payable | 86.71% | -23.95% | 46.37% | 34.16% | 13.26% |
| Total Accrued Expenses | 21.11% | -15.35% | 48.15% | -28.99% | 39.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.86% | -0.45% | 0.45% | 2.26% | 0.23% |
| Total Finance Division Other Current Liabilities | -28.75% | 69.49% | 151.82% | -32.52% | -41.16% |
| Total Other Current Liabilities | -28.75% | 69.49% | 151.82% | -32.52% | -41.16% |
| Total Current Liabilities | 34.92% | -14.81% | 42.07% | -12.73% | 25.47% |
|
|
|||||
| Total Current Liabilities | 34.92% | -14.81% | 42.07% | -12.73% | 25.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.92% | -6.05% | -5.63% | -5.14% | -4.52% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.83% | -12.85% | 27.64% | -10.56% | 15.16% |
|
|
|||||
| Common Stock & APIC | 0.98% | 0.90% | 0.99% | 0.84% | 30.84% |
| Retained Earnings | -11.66% | -10.20% | -13.12% | -10.44% | -11.92% |
| Treasury Stock & Other | 40.83% | -823.08% | 0.00% | -- | -- |
| Total Common Equity | -24.59% | -16.14% | -15.53% | -9.84% | 61.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -24.59% | -16.14% | -15.53% | -9.84% | 61.14% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -24.59% | -16.14% | -15.53% | -9.84% | 61.14% |
|
|
|||||